tafamidis meglumine 20 MG Oral Capsule [Vyndaqel]
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
tafamidis meglumine 20 MG Oral Capsule [Vyndaqel]
20 MG · Oral Capsule · oral
A form of tafamidis meglumine →
tafamidis meglumine 20 MG Oral Capsule [Vyndaqel] — Other nervous system drugs. Strength, form, class, interactions & more.
![tafamidis meglumine 20 MG Oral Capsule [Vyndaqel]](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1b4121ee-a733-4456-a917-be2603477839&name=Fig+2.jpg)
Active ingredient
Classification
Other nervous system drugs
Drug interactions
Tafamidis may increase the exposure and toxicity of certain BCRP substrates when coadministered.
- majorBCRP substrates (e.g., methotrexate, rosuvastatin, imatinib) — increased exposure and risk of substrate-related toxicities
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication